Investigating the Hemodynamic Responses of Women Candidates for Elective Cesarean Section to Two Drugs, Bupivacaine and Ropivacaine: a Systematic Review

Message:
Article Type:
Review Article (دارای رتبه معتبر)
Abstract:
Background

Since the minimum effective dose of the two drugs bupivacaine and Ropivacaine has not been included in the anesthesia reference books and different doses have been suggested for the drugs in the current study, as well as in previous studies, these drugs are combined with other drugs have been used, which affect the side effects and length of anesthesia, in this systematic review study on the hemodynamic changes of patients who are candidates for elective cesarean surgery by spinal anesthesia using two Bupivacaine and Ropivacaine drugs should be evaluated at the minimum dose in terms of low hemodynamic disorders, side effects and anesthesia, and suggest the appropriate drug in this field.

Methodology

In this review article, all databases including Google Scholar, Scopus, Web of Science, PubMed, SID, MagIran, and the Cochrane Library were searched and reviewed by both authors of this article based on PRIZMA guidelines without time and language limitations.

Results

So that the percentage of blood pressure drop in bupivacaine group patients was 50% higher than Ropivacaine group with 23%, and in other words, it can indicate more stability of blood pressure in Ropivacaine group.

Conclusion

Based on this study, statistically, the rate of systolic blood pressure drop, the need for ephedrine, as well as the incidence of nausea and vomiting in patients receiving Ropivacaine were lower, which are important when anesthetizing people with hemodynamic instability, such as pregnant women with Valvular cardiomyopathy can be important.

Language:
English
Published:
Progress in Chemical and Biochemical Research, Volume:6 Issue: 2, May 2023
Pages:
110 to 122
magiran.com/p2588135  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!